The hyperlipemic hamster - A model for testing the anti-atherogenic effect of amlodipine

Journal of Cellular and Molecular Medicine

Volumn 5, Issue 2, 2001, Pages 153-162

  Sima, Anca ^a   Stancu, Camélia ^a   Constantinescu, Elena ^a   Ologeanu, Laura ^a   Simionescu, Maya ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Amlodipine; Atherosclerosis; Electron microscopy; Fluorescent LDL; Hypercholesterolemic hamster; Hyperlipemia; Lipoproteins

Indexed keywords

AMLODIPINE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VASODILATOR AGENT;

ANIMAL; AORTA; ARTERIOSCLEROSIS; ARTICLE; CYTOLOGY; DISEASE MODEL; ELECTRON MICROSCOPY; FLUORESCENCE MICROSCOPY; HAMSTER; HUMAN; MALE; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE; SYRIAN HAMSTER; TIME; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

AMLODIPINE; ANIMALS; AORTA; ARTERIOSCLEROSIS; CRICETINAE; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, LDL; MALE; MESOCRICETUS; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; MUSCLE, SMOOTH; TIME FACTORS; TRIGLYCERIDES; VASODILATOR AGENTS;

EID: 0035527331     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2001.tb00148.x     Document Type: Article

References (30)

1. Stary H.C., The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life, Eur. Heart J., 11: 3-19, 1990
2. Velican C., Velican D., Arterele coronare in cardiopatia ischemica. Editura Medicala/ Romania, Bucuresti, 1992
3. Sima A., Bulla A., Simionescu N., Experimental obstructive coronary atherosclerosis in the hyperlipidemic hamster, J. Submicrosc. Cytol. Pathol, 22: 1-16, 1990
4. Sullivan M.P., Cerda JJ., Robbins F.L., Burgin C.W., Beatty RJ., The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia, Lab. Anini. Sci., 43: 575-78, 1993
5. Bishop R. W., Structure of the hamster LDL receptor gene, J. Lipid Res., 33: 549-57, 1992
6. Chen L., Haught W.H., Yang B., Saldecn T.GR, Parathasarathy S., Metha J., Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine, J./im. Coll. Cardiol.,30: 569-75, 1997
7. Digiesi V., Fiorillo C., Cosmi L., Rossetti M., Lenuzza M., Guidi D., Pace S., Rizzuti G, Nassi P., Reactive oxigen species and antioxidant status in essential arterial hypertension during terapy with dihydropiridine calcium channels antagonist, Clin. Ther., 151: 15-18,2000
8. Tardif J.C., Insights into oxidative stress and atherosclerosis, Can. J. Cardiol, 16: 2D-4,2000
9. Steinberg D., Low density lipoprotein oxidation and its pathobiological significance, J. Biol. Chem., 272: 20963-66, 1997
10. Esterbauer H., Schmidt R., Hayn M., Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis, Advance in Pharmacology, 38: 425-56, 1997
11. Holvoet P., VanCIeemput J., Collen D., Vanhaecke J., Oxidized low density lipoprotein is a prognostic marker of transplant- associated coronary artery disease, Arterioscler. Thromb. Vase. Biol., 20: 698702, 2000
12. Fukumoto M., Shoji T., Emoto M., Kawagishi T., Okuno Y., Nishizawa Y., Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population, Arterioscler. Thromb. Vase. Biol., 20: 703-707, 2000
13. Jones N.L., Reagan J.W., Willingham M.C., The pathogenesis of foam cell formation- Modified LDL stimulates uptake of co-incubated LDL via macropinocytosis, Arterioscler. Thromb. Vase. Biol., 20:773-81,2000
14. Mehrabi M. R., Sinzinger H., Ekmekcioglu C., Tamaddon F., Plesch K., Glogar H.D., Maurer G, Stefenelli T., Lang I.M., Accumulation of oxidized LDL in human semilunar valves correlates with coronary atherosclerosis, Cardiovasc. Res., 45: 874882, 2000
15. Simionescu N., Sima A., Dobrian A., Tirziu D., Simionescu M., Pathobiochemical changes of the arterial wall at the inception of atherosclerosis. In: Vollmer, Roessner (eds.), Current Topics in Pathology, Berlin, Springer Verlag, 1993, pp. 1-45
16. Valkonen M., Kuusi T., Spectrophotometric assay for total peroxyl radical-trapping antioxidant potential in human serum. J. Lipid. Res. 28: 823-833, 1997
17. Innerarity T. L., Pitas R. E., Mahley R. W., Lipoprotein - Receptor Interactions. In: Albers J. J., Segrest J.P., eds. Methods in Enzymology, vol 129, Academic Press, IncAJSA, NY, 1986, pp. 542-546.
18. Filip D.A., Nistor A., Bulla A, Radu A., Lupu F., Simionescu M., Cellular events in the development of valvular atherosclerosis lesions induced by experimental hypercholesterolemia. Atherosclerosis, 67: 199-214, 1987
19. Nistor A., Bulla A., Filip D.A., Radu A., The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis, 68: 159-173, 1987
20. Sima A., Popov D., Starodub O., Stancu C., Cristea C., Stern D., Simionescu M., Pathobiology of the heart in experimental diabetes: immunolocalization of LDL, IgG and AGE-proteins in diabetic and/or hyperlipidemic hamster. Lab. Invest., 77: 3-18, 1997
21. Simionescu M., Simionescu N., Modulations and dysfunctions in the artery intima during the prelesional stage of hypercholesterolemic atherogenesis. In: New Horizons in Coronary Heart Disease. Born GV.R., Schwartz C.J. (eds.), Current Science Ltd., London, pp. 11.1-11.14, 1993
22. Simionescu N., Vasile E., Lupu F., Popescu G, Simionescu M., Prelesional events in atherogenesis: Accumulation of extracellular cholesterol-rich liposomes in the intima and cardiac valves of the hyperlipidemic rabbit. Am. J. Pathol, 123: 109-125, 1986
23. Tirziu D., Dobrian A., Tasca C., Simionescu M., Simionescu N., Intimai thickening of human aorta contain modified reassembled lipoproteins, Alherosclerosis, 112:101-114, 1995
24. Raicu M., Sima A., Toporan D., Stancu C., Protopopescu T., loan AL, Simionescu M., Nifedipine induces a pro-atherogenic effect on smooth muscle cells in culture, incubated with LDL isolated from patients with coronary diseases, Enr.HeartJ., 20:66,1999
25. Raicu M., Pojoga L., Simionescu N., Simionescu M., Differential effect of two calcium channel blockers - nifedipine and diltiazem - in atherogenesis in hypercholesterolemic hamster, J. Sitbmicrosc. Cytol. Pathol, 28 : 265-75, 1996
26. Kowala M.C., Recce R., Beyer S., Aberg G, Regression of early atherosclerosis in hyperlipidemic hamsters induced by fosinopril and captopril, J. Cardiovasc. Pharmacol., 25: 179-86, 1995
27. Kowala M.C., Mazzucco C.E., Hartl K.S., Seiler S.M., Warr GA., Abid S., Growe R.I., Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters, Arteriosclerosis and Thromb., 13: 435-44, 1993
28. Orekhov A.N., Tertov V.V., Pivovarova E.M., The effect of antihypertensive agents on atherosclerosisrelated parameters of human aorta intimai cells, Cardiology, 89: 111-18, 1998
29. Tulenko T.N., Sumner A.E., Chen M., Huang Y., Laury-KIeintop L., Ferdinand F.D., The smooth muscle cell membrane during atherogenesis: a potential target for amlodipine in atheroprotection, Am. Heart J., 141:81-11,2001
30. Kramsch D.M., Limits of lipid-lowering therapy: the potential benefits of amlodipine as an antiatherosclerotic agent, Int. J. Cardiol., 62: S11924,1997